Gilead’s $21,000 Drug Is Being Blamed for a Plateau in HIV Prevention

(Bloomberg) -- In 2012, Gilead Sciences Inc.’s Truvada became the first drug ever approved to prevent HIV, the virus that causes AIDS. It was a public health triumph that was spurred by years of go...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.